Virpax Pharmaceuticals Inc.

0.67
-0.55 (-45.08%)
At close: Apr 03, 2025, 3:57 PM

Virpax Pharmaceuticals Statistics

Share Statistics

Virpax Pharmaceuticals has 1.24M shares outstanding. The number of shares has increased by 21.05% in one year.

Shares Outstanding 1.24M
Shares Change (YoY) 21.05%
Shares Change (QoQ) 17.1%
Owned by Institutions (%) 0%
Shares Floating 1.22M
Failed to Deliver (FTD) Shares 134.87K
FTD / Avg. Volume 33.5%

Short Selling Information

The latest short interest is 350.86K, so 2.36% of the outstanding shares have been sold short.

Short Interest 350.86K
Short % of Shares Out 2.36%
Short % of Float 2.45%
Short Ratio (days to cover) 1.04

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -0.31. Virpax Pharmaceuticals's PEG ratio is 0.

PE Ratio 0
Forward PE -0.31
PS Ratio 0
Forward PS 0
PB Ratio -0.04
P/FCF Ratio 0
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Virpax Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.

Current Ratio 0.63
Quick Ratio 0.63
Debt / Equity 0
Debt / EBITDA 0
Debt / FCF 0
Interest Coverage 116.43

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-6.03B
Employee Count 2
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -99.31% in the last 52 weeks. The beta is 1.42, so Virpax Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.42
52-Week Price Change -99.31%
50-Day Moving Average 5.13
200-Day Moving Average 14.66
Relative Strength Index (RSI) 13.49
Average Volume (20 Days) 402.54K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -12.08B
Net Income -12.07B
EBITDA -12.08B
EBIT -12.17B
Earnings Per Share (EPS) -2836.41
Full Income Statement

Balance Sheet

The company has 1.51M in cash and 0 in debt, giving a net cash position of 1.51M.

Cash & Cash Equivalents 1.51M
Total Debt 0
Net Cash 1.51M
Retained Earnings -71.61B
Total Assets 1.56M
Working Capital -913.76K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.71B and capital expenditures 0, giving a free cash flow of -16.71B.

Operating Cash Flow -16.71B
Capital Expenditures 0
Free Cash Flow -16.71B
FCF Per Share -3928.38
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

VRPX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for VRPX.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Mar 21, 2025. It was a backward split with a ratio of 1:25.

Last Split Date Mar 21, 2025
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score -97.62
Piotroski F-Score 0